Stanford Scholars Explore Generative and Agentic AI for Drug Discovery in Circulation
james_y_zou · x · 2026-08-01
Stanford scholar James Zou and colleagues published a new article in the journal Circulation, discussing the application and potential of generative and agentic AI in drug discovery. The article suggests this exciting technology will bring transformative changes to translational science in complex fields like cardiovascular medicine.
Related event: Stanford Scholars Explore Generative AI in Drug Discovery(3 posts)→
More from Research
- LabEvolver: Robot Scientist Hits 91% Success Rate in Continuous Tasks — imjustnewatai · 2026-08-01
- AI Solves 2-Year-Old Math Conjecture in Minutes with Legible Proof — abeirami · 2026-08-01
- Open-Sourcing Bug-Hunt-Bench: Testing LLMs on 105 Real-World Bugs — PawelHuryn · 2026-08-01
- AI Pharma Bottleneck is Data, Not Models: Industry Shift Expected — MatthewMcAteer0 · 2026-08-01
- Study: Grounding LLMs in Scientific Literature Rarely Improves Behavioral Predictions — duncanjwatts · 2026-08-01
- Minos Co-Authors Genomic AI Paper with OpenAI, Launches HelixForge Data Generator — markjeffrey · 2026-08-01